Trial Profile
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 24 Mar 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 20 Mar 2023 Planned End Date changed from 31 Mar 2023 to 31 Mar 2026.
- 20 Mar 2023 Planned primary completion date changed from 31 Mar 2023 to 31 Mar 2025.
- 11 Mar 2022 Planned End Date changed from 31 Mar 2022 to 31 Mar 2023.